Indications
Reduction of inflammation and relief of pain caused by acute and chronic musculoskeletal disorders.
Composition
- Active substance
- tepoxalin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Zubrin
- Active substance
- tepoxalin
- Group
- Veterinary medicines
- Marketing authorisation holder
- Intervet International BV
- Status
- Withdrawn
- EU authorisation
- 13 Mar 2001
- EMA product number
- EMEA/V/C/000057